Skip to main content

Advertisement

Log in

“I’d feel like someone was watchin’ me… watching for a good reason”: perceptions of data privacy, access, and sharing in the context of real-time PrEP adherence monitoring among HIV-negative MSM with substance use

  • Original Paper
  • Published:
AIDS and Behavior Aims and scope Submit manuscript

Abstract

Once-daily oral tenofovir/emtricitabine is highly effective as pre-exposure prophylaxis (PrEP) against HIV but is dependent on adherence, which may be challenging for men who have sex with men (MSM) and use substances. Digital pill systems (DPS) permit the direct, real-time measurement of adherence, though user perceptions of data privacy in this context are unknown. Thirty prospective DPS users – HIV-negative MSM with non-alcohol substance use – completed in-depth qualitative interviews exploring preferences around privacy, access, and sharing of DPS adherence data. Participants discussed some concerns about the impact of DPS use on personal privacy, and emphasized the need for robust data protections in the technology. Participants were interested in having on-demand access to their adherence data, and were most willing to share data with primary care providers and long-term relationship partners. Future investigations exploring bioethical frameworks around DPS use are warranted, and user preferences should inform best practices for protecting DPS data.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Code Availability

N/A.

References

  1. HIV Surveillance Report. 2019. 32:123.

  2. June 02 CSH govDate last updated:. 2021. U.S. Statistics [Internet]. HIV.gov. 2021 [cited 2021 Jun 16]. Available from: https://www.hiv.gov/hiv-basics/overview/data-and-trends/statistics.

  3. Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, Guanira JV, et al. Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men. Sci Transl Med. 2012 Sep 12;4(151):151ra125-151ra125.

  4. Berry MS, Johnson MW. Does being drunk or high cause HIV sexual risk behavior? A systematic review of drug administration studies. Pharmacol Biochem Behav. 2018 Jan;164:125–38.

    Article  CAS  Google Scholar 

  5. Butler AJ, Rehm J, Fischer B. Health outcomes associated with crack-cocaine use: Systematic review and meta-analyses. Drug Alcohol Depend. 2017 Nov;180:401–16.

    Article  CAS  Google Scholar 

  6. Centers for Disease Control and Prevention. Surveillance HIV, Report. 2018 (Updated) [Internet]. Centers for Disease Control and Prevention; 2020 May [cited 2020 Nov 5]. Report No.: Vol. 31. Available from: http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html.

  7. Grov C, Rendina HJ, Parsons JT, John SA. Determining the Roles that Club Drugs, Marijuana, and Heavy Drinking Play in PrEP Medication Adherence Among Gay and Bisexual Men: Implications for Treatment and Research. AIDS Behav. 2019 May;23(5):1277–86.

    Article  Google Scholar 

  8. Storholm ED, Volk JE, Marcus JL, Silverberg MJ, Satre DD. Risk Perception, Sexual Behaviors, and PrEP Adherence among Substance-Using Men Who Have Sex with Men: A Qualitative Study. Prev Sci Off J Soc Prev Res. 2017 Aug;18(6):737–47.

    Article  Google Scholar 

  9. Safren SA, Blashill AJ, O’Cleirigh CM. Promoting the sexual health of MSM in the context of comorbid mental health problems. AIDS Behav. 2011 Apr;15(S1):30–4.

    Article  Google Scholar 

  10. Taylor SW, Psaros C, Pantalone DW, Tinsley J, Elsesser SA, Mayer KH, et al. “Life-Steps” for PrEP adherence: demonstration of a CBT-based intervention to increase adherence to preexposure prophylaxis (PrEP) medication among sexual-minority men at high risk for HIV acquisition. Cogn Behav Pract. 2017 Feb;24(1):38–49.

    Article  Google Scholar 

  11. Spinelli M, Haberer J, Chai P, Castillo-Mancilla J, Anderson P, Gandhi M. Approaches to objectively measure antiretroviral medication adherence and drive adherence Interventions. Curr HIV/AIDS Rep. 2020;In press.

  12. Castillo-Mancilla JR, Haberer JE. Adherence measurements in HIV: new advancements in pharmacologic methods and real-time monitoring. Curr HIV/AIDS Rep. 2018 Feb;15(1):49–59.

    Article  Google Scholar 

  13. Stirratt MJ, Dunbar-Jacob J, Crane HM, Simoni JM, Czajkowski S, Hilliard ME, et al. Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med. 2015 Dec;5(4):470–82.

    Article  Google Scholar 

  14. Chai PR, Castillo-Mancilla J, Buffkin E, Darling C, Rosen RK, Horvath KJ, et al. Utilizing an ingestible biosensor to assess real-time medication adherence. J Med Toxicol. 2015 Dec;11(4):439–44.

    Article  CAS  Google Scholar 

  15. Stirratt MJ, Curtis JR, Danila MI, Hansen R, Miller MJ, Gakumo CA. Advancing the science and practice of medication adherence. J Gen Intern Med. 2018 Feb;33(2):216–22.

    Article  Google Scholar 

  16. Garrison LE, Haberer JE. Technological methods to measure adherence to antiretroviral therapy and preexposure prophylaxis: Curr Opin HIV AIDS. 2017 Sep;12(5):467–74.

  17. Haberer JE, Baeten JM, Campbell J, Wangisi J, Katabira E, Ronald A, et al. Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa. Siegfried N, editor. PLoS Med. 2013 Sep;10(9):e1001511. 10(.

    Article  Google Scholar 

  18. El Alili M, Vrijens B, Demonceau J, Evers SM, Hiligsmann M. A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence. Br J Clin Pharmacol. 2016 Jul;82(1):268–79.

    Article  Google Scholar 

  19. Baxi SM, Liu A, Bacchetti P, Mutua G, Sanders EJ, Kibengo FM, et al. Comparing the novel method of assessing PrEP adherence/exposure using hair samples to other pharmacologic and traditional measures. JAIDS J Acquir Immune Defic Syndr. 2015 Jan;68(1):13–20.

    Article  CAS  Google Scholar 

  20. Chai P, Rosen R, Boyer E. Ingestible biosensors for real-time medical adherence monitoring: MyTMed. Proc Annu Hawaii Int Conf Syst Sci. 2016;3416–23.

  21. Chai PR, Castillo-Mancilla J, Buffkin E, Darling C, Rosen RK, Horvath KJ, et al. Utilizing an Ingestible Biosensor to Assess Real-Time Medication Adherence. J Med Toxicol. 2015 Dec 1;11(4):439–44.

  22. Chai PR, Goodman G, Bustamante M, Mendez L, Mohamed Y, Mayer KH, et al. Design and delivery of real-time adherence data to men who have sex with men using antiretroviral pre-exposure prophylaxis via an ingestible electronic sensor. AIDS Behav [Internet]. 2020 Nov 21 [cited 2021 Mar 1]; Available from: http://link.springer.com/https://doi.org/10.1007/s10461-020-03082-y.

  23. Martani A, Geneviève LD, Poppe C, Casonato C, Wangmo T. Digital pills: a scoping review of the empirical literature and analysis of the ethical aspects. BMC Med Ethics. 2020 Jan 8;21(1):3.

  24. Chai PR, Mohamed Y, Bustamante MJ, Goodman GR, Najarro J, Castillo-Mancilla J, et al. DigiPrEP: A pilot trial to evaluate the feasibility, acceptability, and accuracy of a digital pill system to measure PrEP adherence in men who have sex with men who use substances. JAIDS J Acquir Immune Defic Syndr [Internet]. 2021 Nov 8 [cited 2021 Dec 14];In press. Available from: https://journals.lww.com/https://doi.org/10.1097/QAI.0000000000002854.

  25. Davis FD. Perceived usefulness, perceived ease of use, and user acceptance of information technology. MIS Q. 1989 Sep;13(3):319–40.

    Article  Google Scholar 

  26. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.

    Article  Google Scholar 

  27. Guest G, MacQueen K, Namey E. Applied thematic analysis. SAGE Publications, Inc.; 2011.

  28. QSR International Pty Ltd. NVivo qualitative data analysis software. 2018.

  29. Chai PR, Goodman G, Bustamante M, Mendez L, Mohamed Y, Mayer KH, et al. Design and Delivery of Real-Time Adherence Data to Men Who Have Sex with Men Using Antiretroviral Pre-exposure Prophylaxis via an Ingestible Electronic Sensor. AIDS Behav. 2021 Jun;25(6):1661–74.

    Article  Google Scholar 

  30. Pew Research Center. Americans and Privacy: Concerned, Confused and Feeling Lack of Control Over Their Personal Information [Internet]. Pew Research Center; 2019 Nov. Available from: https://www.pewresearch.org/internet/2019/11/15/americans-and-privacy-concerned-confused-and-feeling-lack-of-control-over-their-personal-information/.

  31. Montgomery AR. Just what the doctor ordered: protecting privacy without impeding development of digital pills. Vanderbilt J Entertain Technol Law. 2020;19(1):147–75.

    Google Scholar 

  32. de Miguel Beriain I, Morla González M. ‘Digital pills’ for mental diseases: an ethical and social analysis of the issues behind the concept. J Law Biosci. 2020 Jul 25;7(1):lsaa040.

  33. 02 - About Fenway | Fenway Health. Health Care Is A Right, Not A Privilege. [Internet]. [cited 2021 Jul 16]. Available from: https://fenwayhealth.org/about/.

  34. AIDSVu. Local Data: Massachusetts [Internet]. AIDSVu. Available from: https://aidsvu.org/local-data/united-states/northeast/massachusetts/.

Download references

Acknowledgements

We would like to acknowledge etectRx for manufacturing and providing the DPS used in this study, the ID-Cap™ System developed by etectRx.

Funding

This work was supported by Gilead Sciences under ISR 17-1018. PRC is funded by NIH K23DA044874, R44DA051106 and research funding from Gilead Sciences (ISR-17-1018), Hans and Mavis Psychosocial Foundation and e-ink corporation, KM and CO are funded by NIAID P30AI060354, EWB and RKR are funded by NIH R01DA047236. CS, SG, and IGC were supported by a grant from the Collaborative Research Program for Biomedical Innovation Law, a scientifically independent collaborative research program supported by a Novo Nordisk Foundation grant (NNF17SA0027784).

Author information

Authors and Affiliations

Authors

Contributions

Peter R. Chai was the principal investigator and was responsible for the study conception and design. Conall O’Cleirigh, Kenneth H. Mayer, Rochelle K. Rosen, and Edward W. Boyer contributed to the study conception and design. Georgia R. Goodman, Maria J. Bustamante, and Yassir Mohamed contributed to the study methodology, data collection, and data management. Georgia R. Goodman, Maria J. Bustamante, Yassir Mohamed, and Lizette Mendez conducted the qualitative analyses, with oversight from Peter R. Chai and Rochelle K. Rosen. Carmel Shachar, I. Glenn Cohen, and Sara Gerke contributed subject matter and field expertise throughout the process of manuscript preparation. Georgia R. Goodman, Peter R. Chai, and Anna Kikut drafted the manuscript, with contributions and editing from all authors. All authors reviewed and approved the final manuscript.

Corresponding author

Correspondence to Peter R. Chai MD, MMS.

Ethics declarations

Conflicts of Interest/Competing Interests

Glenn Cohen serves as a bioethics consultant to Otsuka on its Abilify MyCite product. The other authors have no relevant financial or non-financial interests to disclose.

Ethics Approval

Approval was obtained from the Fenway Health Institutional Review Board (IRB). The procedures used in this study were in accordance with the Declaration of Helsinki.

Consent to Participate

Informed consent was obtained from all participants in this study.

Consent for Publication

N/A.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic Supplementary Material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Goodman, G.R., Kikut, A., Bustamante, M.J. et al. “I’d feel like someone was watchin’ me… watching for a good reason”: perceptions of data privacy, access, and sharing in the context of real-time PrEP adherence monitoring among HIV-negative MSM with substance use. AIDS Behav 26, 2981–2993 (2022). https://doi.org/10.1007/s10461-022-03614-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-022-03614-8

Keywords

Navigation